Versor Investments LP boosted its stake in DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 60.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,500 shares of the company’s stock after purchasing an additional 9,198 shares during the period. Versor Investments LP’s holdings in DocuSign were worth $2,204,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the stock. Toronto Dominion Bank grew its stake in shares of DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock valued at $1,624,000 after buying an additional 6,081 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in DocuSign by 1.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after acquiring an additional 16,014 shares in the last quarter. Quantinno Capital Management LP boosted its holdings in DocuSign by 39.5% in the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after acquiring an additional 57,104 shares during the period. Robeco Institutional Asset Management B.V. grew its position in DocuSign by 7.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock valued at $80,501,000 after acquiring an additional 85,987 shares in the last quarter. Finally, Rhumbline Advisers grew its position in DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock valued at $54,695,000 after acquiring an additional 330,136 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $86.90, for a total value of $695,200.00. Following the completion of the sale, the chief financial officer now owns 77,851 shares in the company, valued at approximately $6,765,251.90. This represents a 9.32 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 7,763 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total transaction of $625,232.02. Following the transaction, the chief executive officer now directly owns 100,062 shares in the company, valued at $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 693,773 shares of company stock valued at $66,727,926. Company insiders own 1.66% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on DocuSign
DocuSign Price Performance
Shares of DOCU opened at $82.28 on Thursday. DocuSign, Inc. has a 12 month low of $48.70 and a 12 month high of $107.86. The company has a market cap of $16.62 billion, a P/E ratio of 16.96, a PEG ratio of 6.94 and a beta of 0.89. The stock has a fifty day moving average price of $90.91 and a 200 day moving average price of $77.33.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- What Are Dividend Achievers? An Introduction
- These Consumer Staples Shine Amid Market Turmoil
- Why Are Stock Sectors Important to Successful Investing?
- Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
- ETF Screener: Uses and Step-by-Step Guide
- Axon: Long-Term Outlook Is Strong Despite Federal Budget Worries
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.